BrainsWay Ltd. reported $52M of revenue over the trailing twelve months, +27% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $52M (to FY2025). Net income: $7.6M, trailing twelve months to FY2025. Free cash flow: −$1.4M, trailing twelve months to FY2021. Operating margin: 8.3%, trailing twelve months to FY2025.

BWAYBrainsWay Ltd.

Healthcare

$11.23+39% 1Y

$11.23

$7.2552 weeks$17.17

BWAY as reported

BrainsWay Ltd. reported $52M of revenue over the trailing twelve months, +27% on the year before. 10 reported series are charted on this page, each one as filed.

$52M

Revenue, trailing twelve months · to FY2025 · +27% against the twelve months before

Net income: $7.6M
Net income · +159% year on year · trailing twelve months to FY2025
Free cash flow: −$1.4M
Free cash flow · trailing twelve months to FY2021
Operating margin: 8.3%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for BWAY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$52M	+27%	FY2025
Net income	$7.6M	+159%	FY2025
EPS	$0.18	+260%	FY2025
Gross margin	75%	n/a	FY2025
Operating margin	8.3%	n/a	FY2025
Net margin	15%	n/a	FY2025
ROE	10%	n/a	FY2025
ROA	6.7%	n/a	FY2025
Free cash flow	−$1.4M	n/a	FY2021
P/E	62.4	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.